Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene expression profiling identifies WNT7A as a possible candidate gene for decreased cancer risk in fragile X syndrome patients.

Archives of medical research - 1 Feb 2010

Rosales-Reynoso Mónica Alejandra, Ochoa-Hernández Alejandra Berenice, Aguilar-Lemarroy Adriana, Jave-Suárez Luis Felipe, Troyo-Sanromán Rogelio, Barros-Núñez Patricio

Abstract excerpt

BACKGROUND AND AIMS: Although sporadic cases of cancer in patients with fragile X syndrome (FXS) have been reported, extensive studies carried out in Denmark and Finland concluded that cancer incidence in these patients is lower than in the general population. On the other hand, the FMR1 protein, which is involved in the translation process, is absent in FXS patients. Hence, it is reasonable to assume that these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fragile X Syndrome
Share to Gene Expression Profiling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Tumor Suppressor

Share to Molecular Sequence Data

Share to Neoplasms

Share to Oligonucleotide Array Sequence Analysis

Share to Oncogenes

Share to Wnt Proteins

Source

Identifiers

PMID: 20470940
DOI: 10.1016/j.arcmed.2010.03.001

Genes

FMR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene expression profiling identifies WNT7A as a possible candidate gene for decreased cancer risk in fragile X syndrome patients.PMID 20470940Read ↗

Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.Semantic proximity Read ↗

Identification of microRNAs Associated With Human Fragile X Syndrome Using Next Generation SequencingSemantic proximity Read ↗

Fibroblast phenotype in male carriers of FMR1 premutation alleles.Semantic proximity Read ↗

Role of CTCF protein in regulating FMR1 locus transcription.Semantic proximity Read ↗

Alternative splicing in the murine and human FXR1 genes.Semantic proximity Read ↗

Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.Semantic proximity Read ↗

Fragile X Mental Retardation Protein regulates R-loop formation and prevents global chromosome fragilitySemantic proximity Read ↗

Animal model for fragile X syndrome.Semantic proximity Read ↗

Whole genome microarray analysis of gene expression in subjects with fragile X syndromeSemantic proximity Read ↗

Epigenetic mechanism of FMR1 inactivation in Fragile X syndrome.Semantic proximity Read ↗

Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44high/cd24low population which is invasive and resistant to anoikisSemantic proximity Read ↗

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.